EPAS1 and Hepatic fibrosis: Interestingly, when VHL and HIF-1α or HIF-2α were both overexpressed, HIF-1α and HIF-2α were equally effective at preventing the inhibitory effect of VHL on liver fibrosis, and the dominant effect of HIF-2α in toxic liver fibrosis did not exist.